FDA Posts Investigator In Singapore, But Trims Foreign Office List

FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally

FDA continues stretching its criminal enforcement capacity beyond US borders, moving into Southeast Asia, but the agency's Office of International Programs is shrinking its world footprint at the same time.

The Office of Criminal Investigations recently posted an agent in Singapore, the office's second outside the US

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia